SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.556
AS - Asia 5.208
EU - Europa 3.036
SA - Sud America 845
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 99
OC - Oceania 13
Totale 20.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.299
SG - Singapore 1.855
CN - Cina 1.487
BR - Brasile 639
UA - Ucraina 606
VN - Vietnam 541
IT - Italia 488
GB - Regno Unito 437
DE - Germania 426
HK - Hong Kong 411
TR - Turchia 349
FR - Francia 200
PL - Polonia 184
FI - Finlandia 178
SE - Svezia 166
RU - Federazione Russa 128
BD - Bangladesh 125
CA - Canada 116
JP - Giappone 107
IN - India 91
MX - Messico 78
AR - Argentina 73
ZA - Sudafrica 52
IQ - Iraq 48
NL - Olanda 47
BE - Belgio 40
AT - Austria 36
EC - Ecuador 35
CO - Colombia 33
ES - Italia 31
ID - Indonesia 29
PK - Pakistan 24
VE - Venezuela 24
JM - Giamaica 22
UZ - Uzbekistan 16
LT - Lituania 15
CL - Cile 14
IR - Iran 14
PH - Filippine 14
SA - Arabia Saudita 14
MA - Marocco 13
CR - Costa Rica 12
MY - Malesia 12
PY - Paraguay 11
KR - Corea 10
HN - Honduras 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
TN - Tunisia 7
NP - Nepal 6
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
BY - Bielorussia 5
LB - Libano 5
OM - Oman 5
BO - Bolivia 4
CH - Svizzera 4
JO - Giordania 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
MZ - Mozambico 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
Totale 20.754
Salva come PNG Salva come JPEG
Città #
Singapore 1.237
Ashburn 1.212
Woodbridge 891
Fairfield 841
San Jose 787
Jacksonville 620
Houston 610
Chandler 504
Beijing 474
Santa Clara 465
Ann Arbor 458
Hong Kong 405
Council Bluffs 357
Seattle 338
Wilmington 331
Cambridge 283
New York 257
Nanjing 194
Izmir 188
Los Angeles 173
Warsaw 172
Ho Chi Minh City 152
Dallas 144
Hanoi 144
Princeton 134
Tokyo 101
Lauterbourg 97
Buffalo 87
San Diego 87
Munich 78
Milan 73
São Paulo 67
Boardman 63
Shanghai 59
Shenyang 58
Orem 54
Chicago 52
Mexico City 52
Tianjin 52
Helsinki 48
Nanchang 47
Toronto 43
The Dalles 40
Brussels 39
Frankfurt am Main 39
Hefei 39
Hebei 38
Jiaxing 37
San Mateo 34
Brooklyn 32
Ferrara 32
London 30
Montreal 30
Rome 30
Vienna 30
Da Nang 28
Changsha 27
Phoenix 27
San Francisco 27
Chennai 26
Philadelphia 25
Jinan 24
Johannesburg 23
Ningbo 23
Washington 23
Denver 22
Baghdad 21
Guangzhou 21
Naples 21
Norwalk 20
Poplar 20
Stockholm 20
Bologna 19
Boston 19
Falls Church 19
Moscow 19
Rio de Janeiro 19
Kingston 17
Mountain View 17
Turku 17
Ankara 16
Atlanta 16
Augusta 16
Hải Dương 16
Manchester 16
Amsterdam 15
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Brasília 14
Haiphong 14
Verona 14
Charlotte 13
Columbus 13
Medellín 13
Tashkent 13
Belo Horizonte 12
Biên Hòa 12
Curitiba 12
Totale 13.767
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 345
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 292
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 286
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 281
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 273
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 273
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 259
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 258
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 253
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 250
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 248
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 242
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 241
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 236
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 236
HSV as a vector in vaccine development and gene therapy 228
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 224
Capitolo 55 Retrovirus 222
Herpesvirus-based vaccines 218
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 217
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 215
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 214
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 212
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 212
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 211
Replication-competent herpes simplex vectors: design and applications 210
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 206
Herpes Simplex Virus Growth, Preparation, and Assay 204
HSV as a vector in vaccine development and gene therapy 203
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 202
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 199
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 196
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 196
Purinergic Signaling: A New Pharmacological Target Against Viruses? 196
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 193
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 191
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 189
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 189
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 187
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 186
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 183
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 182
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 180
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 180
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 180
null 179
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 178
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 176
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 176
Herpesvirus/retrovirus chimeric vectors 174
Capitolo 44 Herpesviridae 174
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 174
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 173
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 171
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 171
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 170
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 168
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 168
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 167
State of viral DNA in BK virus-transformed rabbit cells 166
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 166
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 166
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 166
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 165
HSV Recombinant Vectors for Gene Therapy 164
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 156
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 156
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 155
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 155
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 154
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 151
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 150
HSV-1 virions engineered for specific binding to cell surface receptors 149
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 148
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 148
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 146
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 143
Transformation by defined regions of herpes simplex virus DNA. 140
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 140
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 138
Molecular diagnosis of herpes simplex encephalitis 137
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 136
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 134
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 134
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 132
Gene therapy of the nervous system by herpes virus vectors 131
Niosomes for vaginal administration of an antiherpetic peptide 130
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale. 129
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 128
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 127
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 121
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 120
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 120
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 118
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 118
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 116
Virus vectors for immunoprophylaxis 115
Molecular approaches to inhibit HIV-1 tat expression and functions 115
TORCH-HERPES SIMPLEX VIRUS 114
Niosomes containing HSV immunogens as possible vaccine against genital herpes 114
Totale 18.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.167
Totale 96.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.126 0 0 0 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20267.128 755 273 643 959 1.054 496 761 357 666 751 312 101
2026/20271.461 245 394 708 114 0 0 0 0 0 0 0 0
Totale 20.865